| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009914A1 Multicloning vector, expression vector, and production of foreign protein with expression vector |
| 04/13/1995 | WO1995009911A1 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 04/13/1995 | WO1995009909A1 An enzyme preparation comprising a modified enzyme |
| 04/13/1995 | WO1995009908A1 Novel tissue plasminogen activator analog |
| 04/13/1995 | WO1995009907A1 Chemical separation using crystals of biological macromolecules |
| 04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995007991A3 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 04/13/1995 | WO1995007989A3 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | DE4334359A1 Epoxy derivatives of polyacrylamides |
| 04/13/1995 | CA2694798A1 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2173214A1 An enzyme preparation comprising a modified enzyme |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647715A1 Genetic engineering of novel plant phenotypes |
| 04/12/1995 | EP0647714A1 Peptidyl prolyl-cis.trans-isomerase |
| 04/12/1995 | EP0647713A1 Peptidyl prolyl-cis.trans-isomerase |
| 04/12/1995 | EP0647712A1 Production of S-adenosyl-methionine (SAM) by fermentation of transformed bacteria |
| 04/12/1995 | EP0647710A1 Novel protease |
| 04/12/1995 | EP0647280A1 Over expression of single-stranded molecules |
| 04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
| 04/12/1995 | EP0647274A1 Recombinant baculoviruses containing insect cellular promoter |
| 04/12/1995 | EP0647273A1 Dna sequences encoding oligosaccharide transporter |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647232A1 Deproteinization with azlactone-functional supports |
| 04/12/1995 | EP0647138A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
| 04/12/1995 | EP0511234B1 Stable injectible solutions for factor viii |
| 04/12/1995 | EP0214971B1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
| 04/11/1995 | US5405943 Tourette syndrom, autism and associated behaviors |
| 04/11/1995 | US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s |
| 04/11/1995 | US5405776 Genetic engineering |
| 04/11/1995 | US5405775 A multicopy single-stranded DNA (msDNA) synthesizing system in Escherichia coli |
| 04/11/1995 | US5405774 DNA encoding a mutated thermostable nucleic acid polymerase enzyme from thermus species sps17 |
| 04/11/1995 | US5405771 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/11/1995 | US5405770 Heliothis subflexa cell line for the production of baculoviruses |
| 04/11/1995 | US5405769 Construction of thermostable mutants of a low molecular mass xylanase |
| 04/11/1995 | US5405768 Genetic engineering |
| 04/11/1995 | US5405767 Adding a carboxylic acid, salt or ester to facilitate precipitation |
| 04/11/1995 | US5405763 A polynucleotides from ARTHROBACTER capable geneic engineering to produce a hydrolases enzyme for hydrolysing a racemic ester of chrysanthemic acid to form a trans acid |
| 04/11/1995 | US5405760 Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA |
| 04/11/1995 | US5405759 Heparitinase, process for producing the same and bacteria producing the same |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/11/1995 | CA1335188C Method for production of human tissue type plasminogen activator |
| 04/11/1995 | CA1335186C Method for purifying tissue plasminogen activator |
| 04/11/1995 | CA1335183C Polypeptide possessing cyclomaltodextrin glucanotransferase activity |
| 04/11/1995 | CA1335182C Cellulose binding fusion proteins |
| 04/06/1995 | WO1995009239A2 Production, purification, cleavage and use of fusion peptides |
| 04/06/1995 | WO1995009238A1 High level expression of human cyclooxygenase-2 |
| 04/06/1995 | WO1995009234A1 Plant-derived phospholipase d gene |
| 04/06/1995 | WO1995009233A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
| 04/06/1995 | WO1995009225A1 A composition and a method for the treatment of dyed fabric |
| 04/06/1995 | WO1995009174A1 Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 04/06/1995 | WO1995009000A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995008914A1 Transgenic cotton plants producing heterologous peroxidase |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995003417A3 Homologously recombinant slow growing mycobacteria and uses therefor |
| 04/06/1995 | CA2172611A1 High level expression of human cyclooxygenase-2 |
| 04/06/1995 | CA2172126A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2170986A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
| 04/05/1995 | EP0646646A2 Protein expression system |
| 04/05/1995 | EP0646645A2 A process for producing a substance |
| 04/05/1995 | EP0646641A2 Method of stabilizing preparation for contact lenses |
| 04/05/1995 | EP0646594A1 Protein purification method |
| 04/05/1995 | EP0646177A1 HETEROLOGOUS GENE EXPRESSION IN $i(BACILLUS SUBTILIS): FUSION APPROACH |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646165A1 Detergent compositions containing lipase and water-soluble quaternary ammonium compounds |
| 04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
| 04/05/1995 | EP0646124A1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
| 04/05/1995 | EP0646115A1 Heterocyclic-cyclic amine derivatives |
| 04/05/1995 | EP0569468B1 Use of an enzyme containing granulate and method for production of a pelletized fodder |
| 04/05/1995 | EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
| 04/05/1995 | EP0422198B1 Phosphorylated plasminogen activators |
| 04/05/1995 | EP0394280B1 Esters of glycosides and a process for enzymatic preparation thereof |
| 04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/04/1995 | US5403918 Fatty acyl reductase |
| 04/04/1995 | US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/04/1995 | US5403737 Serine protease variants having peptide ligase activity |
| 04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 04/04/1995 | US5403726 Enzymatic process for producing a galactosylβ1,3glycal disaccaride using β-galactosidase |
| 04/04/1995 | US5403723 Process for the production of lignolytic enzymes by means of white rot fungi |
| 04/04/1995 | US5403596 Anticoagulant from saliva of leech; does not inhibit thrombin |
| 04/04/1995 | US5403585 Administering an antiiflammatory agent for skin disorders associated with substance P endogenous peptides |
| 04/04/1995 | CA1335084C Nuclease enzyme preparation having high resistance to heat |
| 04/04/1995 | CA1335079C Preventive and curative agents for acquired immune deficiency syndrome (aids) |
| 04/02/1995 | CA2137578A1 Method of stabilizing preparations for contact lenses |
| 03/31/1995 | CA2132937A1 Protein expression system |
| 03/30/1995 | WO1995008645A1 Isolation and composition of novel glycosidases |
| 03/30/1995 | WO1995008641A1 Wilson disease gene |
| 03/30/1995 | WO1995008634A1 Method for generating influenza a viruses bearing attenuating mutations in internal protein genes |
| 03/30/1995 | WO1995008633A1 Plant genetic manipulation |
| 03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | WO1995008624A1 HUMAN PHOSPHOLIPASE C-α AND DNA SEQUENCE CODING FOR THE SAME |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |